PG
ARCC icon

Prostatis Group’s Ares Capital ARCC Stock Holding History

Prostatis Group’s Portfolio ARCC Stock Details ARCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$347K Buy
19,272
+495
+3% +$9.58K 0.09% 125
2025
Q4 		$380K Sell
18,777
-1,966
-9% -$39.7K 0.09% 117
2025
Q3 		$423K Sell
20,743
-1,493
-7% -$33.2K 0.11% 105
2025
Q2 		$488K Buy
22,236
+468
+2% +$9.95K 0.14% 97
2025
Q1 		$482K Buy
21,768
+457
+2% +$10.4K 0.15% 95
2024
Q4 		$467K Buy
21,311
+448
+2% +$9.66K 0.14% 107
2024
Q3 		$437K Buy
20,863
+461
+2% +$9.57K 0.14% 98
2024
Q2 		$425K Buy
20,402
+452
+2% +$9.44K 0.15% 102
2024
Q1 		$415K Hold
19,950
– – 0.16% 101
2023
Q4 		$400K Hold
19,950
– – 0.17% 95
2023
Q3 		$388K Hold
19,950
– – 0.19% 73
2023
Q2 		$375K Sell
19,950
-321
-2% -$5.93K 0.17% 80
2023
Q1 		$371K Buy
+20,271
New +$383K 0.2% 76

Other funds holding ARCC

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $25.2B AUM 30.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
GAM
Generali Asset Management Trieste, Italy $4.79B AUM 26.21% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Prostatis Group's ARCC Position: Q1 2026 in Review

Prostatis Group increased its Ares Capital (ARCC) stake by 2.6% in Q1 2026, buying an estimated $9.58K and bringing the position to 19,272 shares worth $347K. The position accounts for 0.09% of the portfolio, ranked #125.

Prostatis Group first reported a position in ARCC in Q1 2023 and has held it in 13 quarters since. The position peaked at $488K in Q2 2025. 806 funds tracked by Wall St. Rank hold ARCC as of Q1 2026.

  • Prostatis Group held 19,272 shares of Ares Capital worth $347K as of Q1 2026.
  • Prostatis Group bought 495 Ares Capital shares in Q1 2026, an estimated $9.58K.
  • Ares Capital made up 0.09% of Prostatis Group's portfolio in Q1 2026, its #125 holding.
  • Prostatis Group first reported a position in Ares Capital in Q1 2023 and has held it in 13 quarters since.
  • Prostatis Group's Ares Capital position peaked at $488K in Q2 2025.
  • 806 funds tracked by Wall St. Rank held Ares Capital as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.